0001209191-15-061133.txt : 20150716 0001209191-15-061133.hdr.sgml : 20150716 20150716150449 ACCESSION NUMBER: 0001209191-15-061133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150715 FILED AS OF DATE: 20150716 DATE AS OF CHANGE: 20150716 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 15991380 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-07-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2015-07-15 4 M 0 1800 17.16 A 347084 D Common Stock 2015-07-15 4 M 0 10400 35.64 A 357484 D Common Stock 2015-07-15 4 S 0 500 131.77 D 356984 D Common Stock 2015-07-15 4 S 0 2900 133.43 D 354084 D Common Stock 2015-07-15 4 S 0 8200 134.23 D 345884 D Common Stock 2015-07-15 4 S 0 600 135.14 D 345284 D Common Stock 13286 I 401(k) Common Stock 122700 I Common Stock held in trust Stock Option (right to buy) 17.16 2015-07-15 4 M 0 1800 0.00 D 2015-07-19 Common Stock 1800 0 D Stock Option (right to buy) 35.64 2015-07-15 4 M 0 10400 0.00 D 2016-02-01 Common Stock 10400 292000 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $131.77 (range $131.20 to $132.15). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $133.43 (range $132.91 to $133.88). Open market sales reported on this line occurred at a weighted average price of $134.23 (range $133.91 to $134.87). Open market sales reported on this line occurred at a weighted average price of $135.14 (range $135.00 to $135.28). Fully vested. Omar White, Attorney-In-Fact 2015-07-16